Literature DB >> 24948709

Time to smoke first morning cigarette and lung cancer in a case-control study.

Fangyi Gu1, Sholom Wacholder1, Stephanie Kovalchik1, Orestis A Panagiotou1, Carolyn Reyes-Guzman1, Neal D Freedman1, Sara De Matteis1, Dario Consonni1, Pier Alberto Bertazzi1, Andrew W Bergen1, Maria Teresa Landi1, Neil E Caporaso2.   

Abstract

BACKGROUND: Targeting smokers at higher lung cancer risk can improve efficiency and reduce false-positive detection in lung cancer screening. We evaluated whether time to first cigarette after waking (TTFC), a single-item measure of nicotine dependency, could improve stratification of lung cancer risk beyond standard smoking metrics (intensity, duration, and pack-years).
METHODS: In 3249 ever-smokers (n = 1812 case subjects; n = 1437 control subjects) from a population-based case-control study in Italy, we examined the association between TTFC and lung cancer using logistic regression and estimated lung cancer incidence by levels of TTFC, and intensity, duration, and pack-years using absolute risk regression. Significance tests were two-sided.
RESULTS: Compared with smokers with TTFC greater than 60 minutes, the lung cancer odds ratios for TTFC of 31 to 60 minutes, 6 to 30 minutes, and 5 or fewer minutes (by increasing dependency) were 2.57 (95% confidence interval [CI] = 2.03 to 3.26), 2.27 (95% CI = 1.79 to 2.88), and 3.50 (95% CI = 2.64 to 4.64), respectively (P trend < .0001). The average lung cancer incidence rates for smokers of 1 to 10, 11 to 20, 21 to 30 and more than 30 cigarettes per day were consistently higher among smokers with TTFC of 60 or fewer minutes vs more than 60 minutes (64.1 vs 11.7; 125.6 vs 28.6; 130.1 vs 40.7; and 260.8 vs 108.9 per 100000 person-years, respectively). The slopes of increase in lung cancer rates with smoking duration and pack-years were statistically significantly greater among smokers with higher dependency (P interaction < .001).
CONCLUSIONS: Lung cancer risk increases with shorter TTFC; this simple nicotine dependency measure increases lung cancer risk stratification beyond standard smoking measures. Assessing TTFC may improve lung cancer risk prediction and could be useful in lung cancer screening and smoking cessation programs. Published by Oxford University Press 2014.

Entities:  

Mesh:

Year:  2014        PMID: 24948709      PMCID: PMC4072901          DOI: 10.1093/jnci/dju118

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  20 in total

1.  Putting research into context--revisited.

Authors:  Stephanie Clark; Richard Horton
Journal:  Lancet       Date:  2010-07-03       Impact factor: 79.321

2.  Random-effects model for meta-analysis of clinical trials: an update.

Authors:  Rebecca DerSimonian; Raghu Kacker
Journal:  Contemp Clin Trials       Date:  2006-05-12       Impact factor: 2.226

Review 3.  Light and intermittent cigarette smokers: a review (1989-2009).

Authors:  Chris R E Coggins; E Lenn Murrelle; Richard A Carchman; Christian Heidbreder
Journal:  Psychopharmacology (Berl)       Date:  2009-10-03       Impact factor: 4.530

4.  Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.

Authors:  C Martin Tammemagi; Paul F Pinsky; Neil E Caporaso; Paul A Kvale; William G Hocking; Timothy R Church; Thomas L Riley; John Commins; Martin M Oken; Christine D Berg; Philip C Prorok
Journal:  J Natl Cancer Inst       Date:  2011-05-23       Impact factor: 13.506

5.  Nicotine dependence phenotype and lung cancer risk.

Authors:  Joshua E Muscat; Kwangmi Ahn; John P Richie; Steven D Stellman
Journal:  Cancer       Date:  2011-08-08       Impact factor: 6.860

6.  Selection criteria for lung-cancer screening.

Authors:  Martin C Tammemägi; Hormuzd A Katki; William G Hocking; Timothy R Church; Neil Caporaso; Paul A Kvale; Anil K Chaturvedi; Gerard A Silvestri; Tom L Riley; John Commins; Christine D Berg
Journal:  N Engl J Med       Date:  2013-02-21       Impact factor: 91.245

7.  An association of CYP2A6 genotype and smoking topography.

Authors:  Andrew A Strasser; Viba Malaiyandi; Ewa Hoffmann; Rachel F Tyndale; Caryn Lerman
Journal:  Nicotine Tob Res       Date:  2007-04       Impact factor: 4.244

8.  A general binomial regression model to estimate standardized risk differences from binary response data.

Authors:  Stephanie A Kovalchik; Ravi Varadhan; Barbara Fetterman; Nancy E Poitras; Sholom Wacholder; Hormuzd A Katki
Journal:  Stat Med       Date:  2012-08-02       Impact factor: 2.373

9.  Environment And Genetics in Lung cancer Etiology (EAGLE) study: an integrative population-based case-control study of lung cancer.

Authors:  Maria Teresa Landi; Dario Consonni; Melissa Rotunno; Andrew W Bergen; Alisa M Goldstein; Jay H Lubin; Lynn Goldin; Michael Alavanja; Glen Morgan; Amy F Subar; Ilona Linnoila; Fabrizio Previdi; Massimo Corno; Maurizia Rubagotti; Barbara Marinelli; Benedetta Albetti; Antonio Colombi; Margaret Tucker; Sholom Wacholder; Angela C Pesatori; Neil E Caporaso; Pier Alberto Bertazzi
Journal:  BMC Public Health       Date:  2008-06-06       Impact factor: 3.295

10.  Time to first cigarette after waking predicts cotinine levels.

Authors:  Joshua E Muscat; Steven D Stellman; Ralph S Caraballo; John P Richie
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.090

View more
  18 in total

1.  Time to first cigarette and serum cholesterol levels.

Authors:  Arielle S Selya; Naa Dede Hesse
Journal:  Soc Sci Med       Date:  2016-12-30       Impact factor: 4.634

2.  Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial.

Authors:  Alana M Rojewski; Nichole T Tanner; Lin Dai; James G Ravenel; Mulugeta Gebregziabher; Gerard A Silvestri; Benjamin A Toll
Journal:  Chest       Date:  2018-05-21       Impact factor: 9.410

Review 3.  NADPH oxidases: an overview from structure to innate immunity-associated pathologies.

Authors:  Arvind Panday; Malaya K Sahoo; Diana Osorio; Sanjay Batra
Journal:  Cell Mol Immunol       Date:  2014-09-29       Impact factor: 11.530

4.  Response.

Authors:  Fangyi Gu; Sholom Wacholder; Neal D Freedman; Orestis A Panagiotou; Carolyn Reyes-Guzman; Pier Alberto Bertazzi; Neil E Caporaso
Journal:  J Natl Cancer Inst       Date:  2014-11-07       Impact factor: 13.506

5.  Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes.

Authors:  Jingchun Chen; Anu Loukola; Nathan A Gillespie; Roseann Peterson; Peilin Jia; Brien Riley; Hermine Maes; Daniella M Dick; Kenneth S Kendler; M Imad Damaj; Michael F Miles; Zhongming Zhao; Ming D Li; Jacqueline M Vink; Camelia C Minica; Gonneke Willemsen; Dorret I Boomsma; Beenish Qaiser; Pamela A F Madden; Tellervo Korhonen; Pekka Jousilahti; Jenni Hällfors; Joel Gelernter; Henry R Kranzler; Richard Sherva; Lindsay Farrer; Brion Maher; Michael Vanyukov; Michelle Taylor; Jenifer J Ware; Marcus R Munafò; Sharon M Lutz; John E Hokanson; Fangyi Gu; Maria T Landi; Neil E Caporaso; Dana B Hancock; Nathan C Gaddis; Timothy B Baker; Laura J Bierut; Eric O Johnson; Meghan Chenoweth; Caryn Lerman; Rachel Tyndale; Jaakko Kaprio; Xiangning Chen
Journal:  Nicotine Tob Res       Date:  2020-05-26       Impact factor: 4.244

6.  Finding paths with the greatest chance of success: enabling and focusing lung cancer screening and cessation in resource-constrained areas.

Authors:  Wiley D Jenkins; David Gilbert; Li-Shiun Chen; Leslie R Carnahan
Journal:  Transl Lung Cancer Res       Date:  2018-09

7.  Potential Impact of Including Time to First Cigarette in Risk Models for Selecting Ever-Smokers for Lung Cancer Screening.

Authors:  Fangyi Gu; Li C Cheung; Neal D Freedman; Hormuzd A Katki; Neil E Caporaso
Journal:  J Thorac Oncol       Date:  2017-08-14       Impact factor: 15.609

8.  Determinants of Light and Intermittent Smoking in the United States: Results from Three Pooled National Health Surveys.

Authors:  Carolyn M Reyes-Guzman; Ruth M Pfeiffer; Jay Lubin; Neal D Freedman; Sean D Cleary; Paul H Levine; Neil E Caporaso
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-10-19       Impact factor: 4.254

9.  CYP2A6 metabolism in the development of smoking behaviors in young adults.

Authors:  Emily Olfson; Joseph Bloom; Sarah Bertelsen; John P Budde; Naomi Breslau; Andrew Brooks; Robert Culverhouse; Grace Chan; Li-Shiun Chen; David Chorlian; Danielle M Dick; Howard J Edenberg; Sarah Hartz; Dorothy Hatsukami; Victor M Hesselbrock; Eric O Johnson; John R Kramer; Samuel Kuperman; Jacquelyn L Meyers; John Nurnberger; Bernice Porjesz; Nancy L Saccone; Marc A Schuckit; Jerry Stitzel; Jay A Tischfield; John P Rice; Alison Goate; Laura J Bierut
Journal:  Addict Biol       Date:  2016-12-29       Impact factor: 4.280

10.  Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers.

Authors:  Theresa Ryan Stueve; Wen-Qing Li; Jianxin Shi; Crystal N Marconett; Tongwu Zhang; Chenchen Yang; Daniel Mullen; Chunli Yan; William Wheeler; Xing Hua; Beiyun Zhou; Zea Borok; Neil E Caporaso; Angela C Pesatori; Jubao Duan; Ite A Laird-Offringa; Maria Teresa Landi
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.